By Kanchan Joshi | 26 Oct, 2021
Syngene sees medium-term growth prospects intact despite some margin pressure
NEW DELHI : Syngene International Ltd reported strong 17% revenue growth for the September quarter. Most segments contributed to this growth. Key client markets in the US and Europe that are in process of returning to normal operations are helping the company’s discovery services segment. The segment demand is also being helped by newer services such as PROTACS and peptide synthesis. The biologi...
Live Comments
SHIVSHANKAR 2022-09-05 19:15:09
Syngene js subsidiary of Biocon. No need to explain about the fall
Login & Reply Like(0) Dislike(0) Repost Spamparvin 2022-08-01 16:12:38
if it closes above 675 can go to 590 BTST or 2 days time
Login & Reply Like(0) Dislike(0) Repost SpamSTockTips1 2022-07-18 12:05:41
Syngene is bullish on the upside, it's up 12.5% this series and soon it might test 650-660 zone resistance. If you holding Puts then be careful and put SL to avoid losses by way of premium erosion for this series. CP625.2
Login & Reply Like(0) Dislike(0) Repost SpamAnushmita1 2022-07-07 12:24:30
Now loos like it will cross 700 ..... and if crosses 700 plus levels then it will touch 1k guaranteed.......
Login & Reply Like(0) Dislike(0) Repost SpamA1FUTURE_TP1 2022-03-15 14:58:07
I will tell you how to become rich. Close the doors. Be fearful when others are greedy. Be greedy when others are fearful for more detail..bnfs.at/891m
Login & Reply Like(0) Dislike(0) Repost Spam